Fennec Pharmaceuticals (FENC) EBITDA Margin Growth (1y) (2024 - 2025)
Fennec Pharmaceuticals (FENC) EBITDA Margin Growth (1y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 1,997.00 |
| 10 | Fennec Pharmaceuticals | 293.91 Mn | 257.13 Mn | 12.01 Mn | -675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -675.00 |
| Sep 30, 2025 | 7,307.00 |
| Jun 30, 2025 | 4,108.00 |
| Mar 31, 2025 | -6,339.00 |
| Dec 31, 2024 | 689.00 |
| Sep 30, 2024 | -5,898.00 |
| Jun 30, 2024 | 7,094.00 |
| Mar 31, 2024 | 36,841.00 |